skip to main content
Idioma:
Refinado por: assunto: Antineoplastic Agents remover assunto: Medical Sciences remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A new combination chemotherapy for advanced chronic lymphocytic leukemia (vincristine, cyclophosphamide, melphalan, peptichemio, and prednisone protocol)
A new combination chemotherapy for advanced chronic lymphocytic leukemia (vincristine, cyclophosphamide, melphalan, peptichemio, and prednisone protocol)
Material Type:
Artigo 		Adicionar ao Meu Espaço

A new combination chemotherapy for advanced chronic lymphocytic leukemia (vincristine, cyclophosphamide, melphalan, peptichemio, and prednisone protocol)

Ferrara, Felicetto ; Vecchio, Luigi Del ; Mele, Giuseppina ; Rametta, Vincenzo ; Ronconi, Fioravante ; Montuori, Renato

Cancer, 1989-08, Vol.64 (4), p.789-792 [Periódico revisado por pares]

New York: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
2
High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma
High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma
Material Type:
Artigo 		Adicionar ao Meu Espaço

High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma

CAVO, M ; BANDINI, G ; MOTTA, M ; RIZZI, S ; TURA, S ; BENNI, M ; GOZZETTI, A ; RONCONI, S ; ROSTI, G ; ZAMAGNI, E ; LEMOLI, R ; BONINI, A ; BELARDINELLI, A

Bone marrow transplantation (Basingstoke), 1998-07, Vol.22 (1), p.27-32 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
3
Anaplastic large cell lymphoma Hodgkin's-like : A randomized trial of ABVD versus MACOP-B with and without radiation therapy
Anaplastic large cell lymphoma Hodgkin's-like : A randomized trial of ABVD versus MACOP-B with and without radiation therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Anaplastic large cell lymphoma Hodgkin's-like : A randomized trial of ABVD versus MACOP-B with and without radiation therapy

ZINZANI, P. L ; MARTELLI, M ; GHERLINZONI, F ; MORETTI, L ; DE RENZO, A ; MAZZA, P ; PAVONE, E ; SABATTINI, E ; AMENDOLA, A ; BENDANDI, M ; PILERI, S. A ; MANDELLI, F ; MAGAGNOLI, M ; TURA, S ; ZACCARIA, A ; RONCONI, F ; CANTONETTI, M ; BOCCHIA, M ; MARRA, R ; GOBBI, M ; FALINI, B

Blood, 1998-08, Vol.92 (3), p.790-794 [Periódico revisado por pares]

Washington, DC: The Americain Society of Hematology

Texto completo disponível

Citações Citado por
4
Fludarabine-based chemotherapy in untreated mantle cell lymphomas: an encouraging experience in 29 patients
Fludarabine-based chemotherapy in untreated mantle cell lymphomas: an encouraging experience in 29 patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Fludarabine-based chemotherapy in untreated mantle cell lymphomas: an encouraging experience in 29 patients

Zinzani, PL ; Magagnoli, M ; Moretti, L ; Battista, R ; Ronconi, F ; De Renzo, A ; Zaccaria, A ; Gentilini, P ; Guardigni, L ; Gherlinzoni, F ; Cellini, C ; Fattori, PP ; Bendandi, M ; Bocchia, M ; Aitini, E ; Tura, S

Haematologica (Roma), 1999-11, Vol.84 (11), p.1002-1006 [Periódico revisado por pares]

Pavia: Haematologica

Texto completo disponível

Citações Citado por
5
Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma
Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma

Tosi, P ; Zamagni, E ; Cellini, C ; Ronconi, S ; Patriarca, F ; Ballerini, F ; Musto, P ; Di Raimondo, F ; Ledda, A ; Lauria, F ; Masini, L ; Gobbi, M ; Vacca, A ; Ria, R ; Cangini, D ; Tura, S ; Baccarani, M ; Cavo, M

Haematologica (Roma), 2002-04, Vol.87 (4), p.408-414 [Periódico revisado por pares]

Pavia: Haematologica

Texto completo disponível

Citações Citado por
6
Organotin(IV) complexes of ethylsarcosine hydrochloride: synthesis, characterization and in vitro cytotoxic activity
Organotin(IV) complexes of ethylsarcosine hydrochloride: synthesis, characterization and in vitro cytotoxic activity
Material Type:
Artigo 		Adicionar ao Meu Espaço

Organotin(IV) complexes of ethylsarcosine hydrochloride: synthesis, characterization and in vitro cytotoxic activity

Ronconi, L. ; Marzano, C. ; Russo, U. ; Sitran, S. ; Graziani, R. ; Fregona, D.

Applied organometallic chemistry, 2003-01, Vol.17 (1), p.9-16 [Periódico revisado por pares]

Chichester, UK: John Wiley & Sons, Ltd

Texto completo disponível

Citações Citado por
7
A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts
A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts
Material Type:
Artigo 		Adicionar ao Meu Espaço

A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts

MILACIC, Vesna ; DI CHEN ; RONCONI, Luca ; LANDIS-PIWOWAR, Kristin R ; FREGONA, Dolores ; PING DOU, Q

Cancer research (Chicago, Ill.), 2006-11, Vol.66 (21), p.10478-10486 [Periódico revisado por pares]

Philadelphia, PA: American Association for Cancer Research

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de1989  (1)
  2. 1989Até1997  (1)
  3. 1998Até1998  (2)
  4. 1999Até2002  (2)
  5. Após 2002  (2)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.